Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Chen Xiaoguang is active.

Publication


Featured researches published by Chen Xiaoguang.


Journal of Chemotherapy | 2008

The antitumor activity of meisoindigo against human colorectal cancer HT-29 cells in vitro and in vivo.

Zuo Mingxin; Li Yan; Wang Hongbo; Zhou Jianhua; Li Hongyan; Liu He; Xin Hongqi; Chen Xiaoguang

Abstract The study was conducted to examine the antitumor activity of meisoindigo on HT-29 cells In Vitro and In Vivo. The cytotoxicity of meisoindigo was evaluated by MTT assay. The related genes and proteins were inspected with RT-PCR and western blot assay respectively, and the effects of meisoindigo on the cell cycle were analyzed by flow cytometry. The efficacy of meisoindigo In Vivo was evaluated in an HT-29 cell xenograft nude mice model. The results show that meisoindigo effectively inhibits HT- 29 cell proliferation (IC50 4.3 mmol/L), arrests HT-29 cells in G2/ M phase and induces HT-29 cell apoptosis. The downstream genes and proteins of GSK-3β(ser9) expression level decrease. Meisoindigo significantly inhibits the HT-29 xenograft tumors growth at the dose of 100 mg/kg. The mechanism of meisoindigo activity against HT-29 cells may be related to its inhibition of glycogen synthase kinase-3β, GSK-3β(ser9) phosphorylation in Wnt signaling pathway. These findings indicate the potential value of meisoindigo for the treatment of colorectal cancer.


Evidence-based Complementary and Alternative Medicine | 2017

Total Coumarins from Hydrangea paniculata Protect against Cisplatin-Induced Acute Kidney Damage in Mice by Suppressing Renal Inflammation and Apoptosis

Ma Jie; Yang Jingzhi; Wang Dongjie; Zhang Dongming; Chen Xiaoguang

Aim. Hydrangea paniculata (HP) Sieb. is a medical herb which is widely distributed in southern China, and current study is to evaluate renal protective effect of aqueous extract of HP by cisplatin-induced acute kidney injury (AKI) in animal model and its underlying mechanisms. Materials and Methods. HP extract was prepared and the major ingredients were coumarin glycosides. AKI mouse models were established by single i.p. injection of 20 mg/kg cisplatin, and HP was orally administrated for total five times. The renal biochemical functions, pathological staining, kidney oxidative stress, and inflammatory status were measured. Apoptosis of tubular cells and infiltration of macrophages and neutrophils were also tested. Results. HP administration could improve the renal function by decreasing concentration of blood urea nitrogen (BUN) and creatinine and attenuates renal oxidative stress and tubular pathological injury and apoptosis; further research demonstrated that HP could inhibit the overproduction of proinflammatory cytokines and regulate caspase and BCL-2 family proteins. HP also reduced renal infiltration of macrophages and neutrophils, and its effect might be by downregulating phosphorylation of ERK1/2 and stat3 signaling pathway. Conclusions. This present study suggests that HP could ameliorate cisplatin induced kidney damage by antioxidation and suppressing renal inflammation and tubular cell apoptosis.


Archive | 2004

Coumarin amide derivative and its prepn, medicinal composition and use

Xu Shiping; Xie Longfei; Xu Song; Li Lanmin; Li Yan; Li Hongyan; Chen Xiaoguang; Cheng Guifang


Archive | 2005

Application of skimming in the preparing process of medicine for preventing and treating kidney function failure

Zhang Dongming; Chen Xiaoguang; Yang Jingzhi


Archive | 2006

Novel coumarin-amide derivatives and its preparation, its drug composition and use

Xu Shiping; Xie Longfei; Xu Song; Li Lanmin; Li Yan; Li Hongyan; Chen Xiaoguang; Cheng Guifang


American Journal of Translational Research | 2017

Nicousamide protects kidney podocyte by inhibiting the TGFβ receptor II phosphorylation and AGE-RAGE signaling

Jin Jing; Chen Xiaoguang; Lai Fangfang; Xue Nina; Wang Dongjie; Ji Ming


Archive | 2016

Application of chlorogenic acid in preparing drug for treating diseases with LAG-3 as target spot

Zhang Jie; Chen Xiaoguang; Xue Nina; Zhang Mengtian


Archive | 2013

Cephalotamannine derivative, its production, its medicinal composition and use

Li Xuan; Zhao Limin; Han Rui; Yang Chungang; Wang Hongbo; Fang Weishuo; Liu Hongyan; Chen Xiaoguang


Archive | 2006

Coumarin derivatives, their preparation methods and their pharmaceutic compositions and uses

Xie Ping; Chen Xiaoguang; Xu Shiping; Li Hongyan; Li Lanmin; Zhou Yanli; Liu Yue; Luo Zhigang; Jiao Xiaozhen; Zheng Xuguang; Zhang Furong


Archive | 2017

Piperazinone-containing quinazolinone PARP-1/2 inhibitor, and preparation method, medicine composition and purpose thereof

Xu Bailing; Chen Xiaoguang; Zhou Jie; Ji Ming; Yao Haiping; Zhou Qin

Collaboration


Dive into the Chen Xiaoguang's collaboration.

Top Co-Authors

Avatar

Jin Jing

Peking Union Medical College

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Xie Ping

Peking Union Medical College

View shared research outputs
Researchain Logo
Decentralizing Knowledge